Want to join the conversation?
For 1Q16, $AMAT expects net sales to be down 2-9% sequentially and non-GAAP adjusted diluted EPS is expected to be in the range of $0.23-0.27. $AMAT's backlog remained essentially flat at $3.14Bil and included negative adjustments of $13MM.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)